https://www.selleckchem.com/
Multiple epidemiologic and genetic risk factors, as well as serum biomarkers, have been associated with RA-ILD. Subclinical and clinical ILD occur frequently in preclinical, early, and established RA and may play a key role in RA-related autoantibody production and disease progression. Further studies are needed to better understand the risk factors, prognosis, and potential therapies for RA-ILD. Subclinical and clinical ILD occur frequently in preclinical, early, and established RA and may play a key role in RA-related autoantibody production and disease p
Like
Comment
Share
